Does Arcutis Biotherapeutics (ARQT) Pay a Dividend? (2026)
Short answer
Arcutis Biotherapeutics (ARQT) pays little or no dividend; like many growth-oriented companies it reinvests cash rather than paying income. A dividend is a slice of profits returned to shareholders, and the yield is that payout divided by the share price, so it drifts as both change. Figures here are approximate; verify the current number with your broker.
Does Arcutis Biotherapeutics (ARQT) pay a dividend?
Arcutis Biotherapeutics (ARQT) currently returns little or nothing as a dividend. As of MAY 2026, Arcutis trades as a high-growth, single-franchise dermatology name rather than a stable earner, so its valuation leans on ZORYVE's revenue trajectory and the durability of its early profitability. With a market cap near $3 billion against roughly $372 million of 2025 sales, the price-to-sales multiple reflects growth expectations, and the stock is sensitive to any change in prescription momentum or guidance. Because full-year GAAP profitability is not yet consistent, trailing P/E is not a meaningful anchor.
How to think about ARQT's dividend
- Yield is a snapshot: minimal today, but it moves with price and payout.
- Total return vs income: dividends are one part of return; price change is usually the bigger part for a name like ARQT.
- Reinvest or take income: a DRIP compounds; taking the cash gives income now.
- For more yield: dedicated dividend stocks and ETFs target higher payouts. See the best dividend ETFs.
The bottom line on the ARQT dividend
Arcutis Biotherapeutics (ARQT) is not an income stock; if you own it, it is for growth or total return, not the dividend. For the full picture see the ARQT guide. Walnut can show how ARQT fits your real portfolio. It is not an investment adviser.
Build a basket around ARQT with Walnut
Use Arcutis Biotherapeutics as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Does Arcutis Biotherapeutics (ARQT) pay a dividend?
+
Arcutis Biotherapeutics (ARQT) pays little or no dividend; like many growth-stage companies it tends to reinvest cash rather than return it as income. Verify the current policy on ARQT's investor relations page.
What is ARQT's dividend yield?
+
ARQT's yield is minimal or zero. Companies prioritizing growth often pay no dividend and return cash through buybacks instead, if at all.
How often does ARQT pay its dividend?
+
US companies that pay dividends, like Arcutis Biotherapeutics if it does, typically distribute them quarterly. Confirm the exact schedule and ex-dividend dates on ARQT's investor relations page before relying on the timing.
Can I reinvest ARQT dividends?
+
Yes. Most brokers offer automatic dividend reinvestment (a DRIP) so any ARQT dividend buys more shares automatically. It compounds over time but is still taxable in a taxable account.
Is ARQT a good dividend stock?
+
Walnut is informational, not investment advice. ARQT is a growth or total-return name rather than an income stock. Dedicated dividend stocks and ETFs target higher, steadier yield; match the choice to whether you want income now or growth.
Does Arcutis pay a dividend?
+
No. Arcutis does not pay a dividend. Like most growth-stage biopharma companies, it reinvests cash into its commercial expansion, sales force, and pipeline, so any return would come from share-price changes rather than income.
Walnut is informational, not investment advice. Dividend figures are approximate and dated; verify current yield, schedule, and policy with ARQT's investor relations page or your broker.